Current Status of Hepatocyte Transplantation
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Hepatocyte transplantation (HT) has been performed in patients with liver-based metabolic disease and acute liver failure as a potential alternative to liver transplantation. The results are encouraging in genetic liver conditions where HT can replace the missing enzyme or protein. However, there are limitations to the technique, which need to be overcome. Unused donor livers to isolate hepatocytes are in short supply and are often steatotic, although addition of N-acetylcysteine improves the quality of the cells obtained. Hepatocytes are cryopreserved for later use and this is detrimental to metabolic function on thawing. There are improved cryopreservation protocols, but these need further refinement. Hepatocytes are usually infused into the hepatic portal vein with many cells rapidly cleared by the innate immune system, which needs to be prevented. It is difficult to detect engraftment of donor cells in the liver, and methods to track cells labeled with iron oxide magnetic resonance imaging contrast agents are being developed. Methods to increase cell engraftment based on portal embolization or irradiation of the liver are being assessed for clinical application. Encapsulation of hepatocytes allows cells to be transplanted intraperitoneally in acute liver failure with the advantage of avoiding immunosuppression. Alternative sources of hepatocytes, which could be derived from stem cells, are needed. Mesenchymal stem cells are currently being investigated particularly for their hepatotropic effects. Other sources of cells may be better if the potential for tumor formation can be avoided. With a greater supply of hepatocytes, wider use of HT and evaluation in different liver conditions should be possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · cited 1×
“This would be greatly enhanced if good quality hepatocytes could be isolated from steatotic donor livers, which are becoming more common with the increasing incidence of obesity in the population (14).”
BackgroundImmunogenicity of induced pluripotent stem cells
Zhao, T., Zhang, Z.-N., Rong, Z., & Xu, Y. (2011) · Nature · doi:10.1038/nature10135 · Cited by 1,444
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
Fox, I. J., Chowdhury, J. R., Kaufman, S. S., Goertzen, T. C., Chowdhury, N. R., Warkentin, P. I., Dorko, K., Sauter, B. V., & Strom, S. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382004 · Cited by 1,023 · cited 1×
“(23, 24) with the aim of replacing 5% of liver cell mass.”
Backgroundvan Poll, D., Parekkadan, B., Cho, C. H., Berthiaume, F., Nahmias, Y., Tilles, A. W., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22236 · Cited by 501
Human Hepatocyte Transplantation: Worldwide Results
Fisher, R. A., & Strom, S. C. (2006) · Transplantation · doi:10.1097/01.tp.0000231689.44266.ac · Cited by 445
Hepatocyte Transplantation for the Treatment of Human Disease
Strom, S., Chowdhury, J., & Fox, I. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007096 · Cited by 366
Human hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362
Self-citationJohansson, H., Lukinius, A., Moberg, L., Lundgren, T., Berne, C., Foss, A., Felldin, M., Källen, R., Salmela, K., Tibell, A., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1755 · Cited by 328
Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue
Zhao, Y., Terry, D. S., Shi, L., Quick, M., Weinstein, H., Blanchard, S. C., & Javitch, J. A. (2011) · Nature · doi:10.1038/nature09971 · Cited by 311
HUMAN FETAL HEPATOCYTE TRANSPLANTATION IN PATIENTS WITH FULMINANT HEPATIC FAILURE
Habibullah, C. M., Syed, I. H., Qamar, A., & Taher-Uz, Z. (1994) · Transplantation · doi:10.1097/00007890-199410270-00016 · Cited by 301 · cited 7×
“Cell-labeling experiments in rats with ALF were performed and are currently being analyzed.”
BackgroundInfluentialIsolated Hepatocyte Transplantation in an Infant With a Severe Urea Cycle Disorder
Horslen, S. P., McCowan, T. C., Goertzen, T. C., Warkentin, P. I., Cai, H. B., Strom, S. C., & Fox, I. J. (2003) · Pediatrics · doi:10.1542/peds.111.6.1262 · Cited by 295 · cited 1×
“(23, 24) with the aim of replacing 5% of liver cell mass.”
BackgroundGupta, S., Rajvanshi, P., Sokhi, R., Slehria, S., Yam, A., Kerr, A., & Novikoff, P. M. (1999) · Hepatology · doi:10.1002/hep.510290213 · Cited by 282 · cited 1×
“In animals, the innate immune system rapidly cleared more than 70% of the transplanted cells mainly through Kupffer cells within 24 hr, irrespective of whether syngeneic or allogeneic hepatocytes were used (25, 26).”
BackgroundHepatocyte Transplantation for Inherited Factor VII Deficiency
Dhawan, A., Mitry, R. R., Hughes, R. D., Lehec, S., Terry, C., Bansal, S., Arya, R., Wade, J. J., Verma, A., Heaton, N. D., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000146386.77076.47 · Cited by 262 · cited 5×
“The authors thank the Liver Transplant and Hepatobili- ary Surgery teams, Transplant Coordinators, and members of the Hepatocyte Biology and Transplantation Group at King’s College Hospital.”
BackgroundSelf-citationStéphenne, X., Najimi, M., Sibille, C., Nassogne, M., Smets, F., & Sokal, E. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.008 · Cited by 213 · cited 1×
“Clear evidence of donor hepatocyte engraftment into recipient liver with sustained engraftment and tissue enzyme activity for up to 12 months after HT was obtained in a 3-year-old girl with argininosuccinate lyase deficiency (35).”
BackgroundFox, I. J., & Roy-Chowdhury, J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.04.009 · Cited by 197
Hepatocyte transplantation for liver‐based metabolic disorders
Dhawan, A., Mitry, R. R., & Hughes, R. D. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0245-8 · Cited by 195
Self-citationHuman hepatocyte transplantation: state of the art
Fitzpatrick, E., Mitry, R. R., & Dhawan, A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02152.x · Cited by 155 · cited 1×
“Studies have demonstrated that various types of progenitor/stem cells can be isolated from both adult and fetal livers and have the potential to generate functional hepatocytes (41, 42).”
BackgroundSelf-citationMesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo
Yan, Y., Xu, W., Qian, H., Si, Y., Zhu, W., Cao, H., Zhou, H., & Mao, F. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01855.x · Cited by 152 · cited 1×
“An important property of mesenchymal stem cells (MSC) is that they can provide trophic support to injured livers by inhibiting hepatocyte death and stimulating proliferation (47, 48).”
BackgroundStéphenne, X., Najimi, M., Smets, F. N., Reding, R., de Goyet, J. D. V., & Sokal, E. M. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00935.x · Cited by 144 · cited 1×
“Cryopreserved cells alone have been transplanted in some patients with good metabolic effect (5, 17).”
BackgroundKupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver
Joseph, B., Malhi, H., Bhargava, K. K., Palestro, C. J., McCuskey, R. S., & Gupta, S. K. (2002) · Gastroenterology · doi:10.1053/gast.2002.36592 · Cited by 140 · cited 1×
“In animals, the innate immune system rapidly cleared more than 70% of the transplanted cells mainly through Kupffer cells within 24 hr, irrespective of whether syngeneic or allogeneic hepatocytes were used (25, 26).”
BackgroundHepatic irradiation augments engraftment of donor cells following hepatocyte transplantation†
Yamanouchi, K., Zhou, H., Roy‐Chowdhury, N., Macaluso, F., Liu, L., Yamamoto, T., Yannam, G. R., Enke, C., Solberg, T. D., Adelson, A. B., et al. (2009) · Hepatology · doi:10.1002/hep.22573 · Cited by 139 · cited 2×
“Hepatic irradiation increased donor hepatocyte engraftment in the liver parenchyma in rats in a dose-dependent fashion (54).”
BackgroundBhogal, R. H., Hodson, J., Bartlett, D. C., Weston, C. J., Curbishley, S. M., Haughton, E., Williams, K. T., Reynolds, G. M., Newsome, P. N., Adams, D. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018222 · Cited by 136 · cited 1×
“Recently, it was reported that good quality hepatocytes could be obtained from diseased livers removed at transplantation (16).”
BackgroundMitry, R. R., Dhawan, A. K., Hughes, R. D., Bansal, S., Lehec, S. C., Terry, C., Heaton, N. D., Karani, J. B., Mieli‐Vergani, G., & Rela, M. (2004) · Transplantation · doi:10.1097/01.tp.0000122224.98318.19 · Cited by 131 · cited 1×
“To date, we have carried out more than 200 hepatocyte isolations from a range of lobes/ segments, including segment IV obtained when splitting livers for two liver transplant recipients (12).”
BackgroundSelf-citationCryopreservation of isolated human hepatocytes for transplantation: State of the art
Terry, C., Dhawan, A., Mitry, R. R., & Hughes, R. D. (2006) · Cryobiology · doi:10.1016/j.cryobiol.2006.05.004 · Cited by 117 · cited 1×
“However, cryopreservation has detrimental effects on the viability and metabolic function of hepatocytes so that on thawing cells are often not suitable for clinical use (18, 19).”
BackgroundSelf-citationPuppi, J., Tan, N., Mitry, R. R., Hughes, R. D., Lehec, S., Mieli-Vergani, G., Karani, J., Champion, M. P., Heaton, N., Mohamed, R., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02058.x · Cited by 116 · cited 4×
“The authors thank the Liver Transplant and Hepatobili- ary Surgery teams, Transplant Coordinators, and members of the Hepatocyte Biology and Transplantation Group at King’s College Hospital.”
BackgroundSelf-citationTerry, C., Dhawan, A., Mitry, R. R., Lehec, S. C., & Hughes, R. D. (2010) · Liver Transplantation · doi:10.1002/lt.21983 · Cited by 115 · cited 1×
“In a recent study, the different steps involved in the hepatocyte cryopreservation and thawing process, including cell density, addition of cryoprotectants, freezing temperature program, and thawing method, were investigated systematically (21).”
MethodSelf-citationHuman Hepatocyte Isolation and Relationship of Cell Viability to Early Graft Function
Mitry, R. R., Hughes, R. D., Aw, M. M., Terry, C., Mieli-Vergani, G., Girlanda, R., Muiesan, P., Rela, M., Heaton, N. D., & Dhawan, A. (2003) · Cell Transplantation · doi:10.3727/000000003783985197 · Cited by 113 · cited 1×
“nique is used to digest donor liver tissue, and the cells are purified by centrifugation (11).”
MethodSelf-citationIsolation of hepatocytes from livers from non-heart-beating donors for cell transplantation
Hughes, R. D., Mitry, R. R., Dhawan, A., Lehec, S. C., Girlanda, R., Rela, M., Heaton, N. D., & Muiesan, P. (2006) · Liver Transplantation · doi:10.1002/lt.20732 · Cited by 93 · cited 1×
“Human hepatocytes are isolated from liver tissues rejected/unused for transplantation, including livers from non-heart-beating donors (10).”
BackgroundSelf-citationThe Instant Blood-Mediated Inflammatory Reaction Characterized in Hepatocyte Transplantation
Gustafson, E. K., Elgue, G., Hughes, R. D., Mitry, R. R., Sanchez, J., Haglund, U., Meurling, S., Dhawan, A., Korsgren, O., & Nilsson, B. (2011) · Transplantation · doi:10.1097/tp.0b013e31820ae459 · Cited by 93 · cited 1×
“In vitro perfusion experiments and assays in a patient receiving HT showed immediate activation of both coagulation and complement, also possibly related to expression of tissue factor (29).”
BackgroundSelf-citationMei, J., Sgroi, A., Mai, G., Baertschiger, R., Gonelle-Gispert, C., Serre-Beinier, V., Morel, P., & Bühler, L. H. (2009) · Cell Transplantation · doi:10.3727/096368909788237168 · Cited by 92
Wang, L., Chen, Y. M., George, D., Smets, F., Sokal, E. M., Bremer, E. G., & Soriano, H. E. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34891 · Cited by 92 · cited 1×
“Direct evidence of engraftment is restricted to identification of donor sex chromosome or human leukocyte antigens in cases of donor-recipient sex or human leukocyte antigen mismatch or genetic typing of liver biopsies (33, 34).”
BackgroundCell-mediated rejection results in allograft loss after liver cell transplantation
Allen, K. J., Mifsud, N. A., Williamson, R., Bertolino, P., & Hardikar, W. (2008) · Liver Transplantation · doi:10.1002/lt.21443 · Cited by 89 · cited 1×
“Hepatocytes stimulate a cell-mediated immune response evoked by both CD4 and CD8 T cells, which may contribute to the gradual loss of graft function that is observed (30, 31).”
BackgroundCryopreservation-Induced Nonattachment of Human Hepatocytes: Role of Adhesion Molecules
Terry, C., Hughes, R. D., Mitry, R. R., Lehec, S. C., & Dhawan, A. K. (2007) · Cell Transplantation · doi:10.3727/000000007783465000 · Cited by 79 · cited 1×
“Studies have been performed to determine the effects of freezing, particularly on cell attachment and integrin-B1 expression (20).”
BackgroundSelf-citationProspects For Stem Cell Transplantation in the Treatment of Hepatic Disease
Stutchfield, B. M., Forbes, S. J., & Wigmore, S. J. (2010) · Liver Transplantation · doi:10.1002/lt.22083 · Cited by 76 · cited 1×
“Hepatocyte-like cells can be derived from other sources particularly human embryonic stem cells and induced pluripotent cells (44).”
BackgroundStéphenne, X., Vosters, O., Najimi, M., Beuneu, C., Ngoc, D. K., Wijns, W., Goldman, M., & Sokal, E. M. (2007) · Liver Transplantation · doi:10.1002/lt.21128 · Cited by 76 · cited 1×
“Inhibition of tissue factor-dependent procoagulant activity with N-acetylcysteine could be beneficial (28).”
BackgroundHepatocyte Transplantation for Metabolic Liver Disease: UK Experience
Hughes, R. D., Mitry, R. R., & Dhawan, A. K. (2005) · Journal of the Royal Society of Medicine · doi:10.1177/014107680509800803 · Cited by 71
Self-citationBOHNEN, N. I., CHARRON, M., REYES, J., RUBINSTEIN, W., STROM, S. C., SWANSON, D., & TOWBIN, R. (2000) · Clinical Nuclear Medicine · doi:10.1097/00003072-200006000-00012 · Cited by 69 · cited 1×
“Cell labeling with radioactive indium was used in a patient to demonstrate hepatocyte biodistribution after transplantation (37).”
MethodCellular Loss After Allogenic Hepatocyte Transplantation
Han, B., Lu, Y., Meng, B., & Qu, B. (2009) · Transplantation · doi:10.1097/tp.0b013e3181919212 · Cited by 68 · cited 1×
“Hepatocytes stimulate a cell-mediated immune response evoked by both CD4 and CD8 T cells, which may contribute to the gradual loss of graft function that is observed (30, 31).”
BackgroundMassie, I., Selden, C., Hodgson, H. J. F., & Fuller, B. J. (2011) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2010.0394 · Cited by 64 · cited 1×
“As with hepatocytes, methods of cryopreserving hepatocyte microbeads are essential for emergency use in patients (59).”
MethodDagher, I., Nguyen, T. H., Groyer‐Picard, M., Lainas, P., Mainot, S., Guettier, C., Pariente, D., Franco, D., & Weber, A. (2009) · Hepatology · doi:10.1002/hep.22739 · Cited by 63 · cited 1×
“Temporary embolization of the portal vein with an absorbable material generated ischemia-reperfusion injury and stimulated a regenerative response to repopulate non-human primates with hepatocytes expressing a transgene (51).”
BackgroundEfficient Hepatocyte Engraftment in a Nonhuman Primate Model After Partial Portal Vein Embolization
Dagher, I., Boudechiche, L., Branger, J., Coulomb-Lhermine, A., Parouchev, A., Sentilhes, L., Lin, T., Groyer-Picard, M.-T., Vons, C., Hadchouel, M., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000236103.99456.8f · Cited by 62 · cited 1×
“Partial reversible embolization of the portal vein and subsequent autologous HT in Macaca monkeys resulted in replacement of 10% of liver mass (50).”
BackgroundThe Effects of Cryopreservation on Human Hepatocytes Obtained from Different Sources of Liver Tissue
Terry, C., Mitry, R. R., Lehec, S. C., Muiesan, P., Rela, M., Heaton, N. D., Hughes, R. D., & Dhawan, A. (2005) · Cell Transplantation · doi:10.3727/000000005783982765 · Cited by 60 · cited 1×
“However, cryopreservation has detrimental effects on the viability and metabolic function of hepatocytes so that on thawing cells are often not suitable for clinical use (18, 19).”
BackgroundSelf-citationLiver after Hepatocyte Transplantation for Liver-Based Metabolic Disorders in Children
Quaglia, A., Lehec, S. C., Hughes, R. D., Mitry, R. R., Knisely, A. S., Devereaux, S., Richards, J., Rela, M., Heaton, N. D., Portmann, B. C., et al. (2008) · Cell Transplantation · doi:10.3727/096368908787648083 · Cited by 53
Self-citationMalhi, H., Joseph, B., Schilsky, M. L., & Gupta, S. K. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.2.165 · Cited by 52 · cited 1×
“Radiation was also used for liver preconditioning with and without transient portal vein branch occlusion before HT in a rat model of Wilson disease (53).”
MethodUse of a Clinically Approved Iron Oxide MRI Contrast Agent to Label Human Hepatocytes
Puppi, J., Mitry, R. R., Modo, M., Dhawan, A., Raja, K. B., & Hughes, R. D. (2011) · Cell Transplantation · doi:10.3727/096368910x543367 · Cited by 51 · cited 1×
“Labeled hepatocytes could be detected after intrasplenic transplantation into nonobese diabetic severe combined immunodeficiency mice by magnetic resonance imaging (38).”
BackgroundSelf-citationSagias, F., Mitry, R. R., Hughes, R. D., Lehec, S. C., Patel, A. G., Rela, M., Mieli‐Vergani, G., Heaton, N. D., & Dhawan, A. (2010) · Cell Transplantation · doi:10.3727/096368910x514620 · Cited by 50 · cited 1×
“Addition of the antioxidant N-acetylcysteine to the perfusion solution when isolating hepatocytes from fatty liver gave significant improvement in cell viability and metabolic function (15).”
BackgroundSelf-citationHepatocyte xenotransplantation for treating liver disease
Bonavita, A. G. C., Lima-Quaresma, K. R. F., Cotta-de-Almeida, V., Pinto, M. A., Saraiva, R. M., & Alves, L. A. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00588.x · Cited by 44 · cited 1×
“Transplantation of xenogeneic hepatocytes has also been suggested to overcome the shortage of donor organs (46).”
BackgroundMas, V. R., Maluf, D. G., Thompson, M. T., Ferreira‐Gonzalez, A., & Fisher, R. A. (2004) · Cell Transplantation · doi:10.3727/000000004783983945 · Cited by 35 · cited 1×
“Direct evidence of engraftment is restricted to identification of donor sex chromosome or human leukocyte antigens in cases of donor-recipient sex or human leukocyte antigen mismatch or genetic typing of liver biopsies (33, 34).”
BackgroundIrradiation as preparative regimen for hepatocyte transplantation causes prolonged cell cycle block
Koenig, S., Krause, P., Schmidt, T.-K., Rave‐Fränk, M., Rothe, H., Hermann, R. M., Becker, H., Hess, C. F., & Christiansen, H. (2008) · International Journal of Radiation Biology · doi:10.1080/09553000801953359 · Cited by 33 · cited 1×
“Liver irradiation has been investigated in rats and inhibition of native hepatocyte proliferation induced by irradiation promoted preferential proliferation of transplanted hepatocytes after partial hepatectomy (52).”
BackgroundNajimi, M., Smets, F. N., & Sokal, E. M. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-201-4_6 · Cited by 28 · cited 1×
“The mechanisms by which allogeneic hepatocytes are rejected are complex, and other nonspecific mechanisms, such as apoptosis (32), could also contribute to cell loss.”
BackgroundKammer, N. N., Billecke, N., Morgül, M. H., Adonopoulou, M. K., Mogl, M. T., Huang, M. D., Florek, S., Schmitt, K. R. L., Raschzok, N., & Sauer, I. M. (2011) · Artificial Organs · doi:10.1111/j.1525-1594.2010.01177.x · Cited by 7 · cited 1×
“Others have used larger micronsized iron oxide particles which are not yet available for clinical use but have the advantage that hepatocytes can be labeled in suspension (39).”
BackgroundLeconte, I., Pallu, S., Abarca‐Quinones, J., Michoux, N., Peeters, F., Radermacher, K. A., Sempoux, C. L., Najimi, M., Sokal, E. M., & BEERS, B. E. V. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22255 · Cited by 7 · cited 1×
“When given to mice, the iron particles were detected in Kupffer cells after 7 days rather than in hepatocytes (40).”
Background
Cited by
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Rezvani, M., Español-Suñer, R., Malato, Y., Dumont, L., Grimm, A. A., Kienle, E., Bindman, J. G., Wiedtke, E., Hsu, B. Y., Naqvi, S. J., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.05.005 · Cited by 150
Smith, A. R., Rizvi, F., Everton, E., Adeagbo, A., Wu, S., Tam, Y., Muramatsu, H., Pardi, N., Weissman, D., & Gouon-Evans, V. (2024) · Nature Communications · doi:10.1038/s41467-024-49332-8 · Cited by 18
The road to regenerative liver therapies: the triumphs, trials and tribulations
Raju, R., Chau, D., Verfaillie, C. M., & Hu, W.-S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.022 · Cited by 14
Metadata
- Authors
- Hughes, R. D., Mitry, R. R., & Dhawan, A.
- Venue
- Transplantation
- Published
- 2012-02-27
- Volume
- 93
- Issue
- 4
- Pages
- 342-347
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2087967001
- Cited by
- 187
- References
- 52
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.